Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Sulfonamide-containing indole compounds

a technology of indole and sulfonamide, which is applied in the direction of heterocyclic compound active ingredients, drug compositions, biocides, etc., can solve the problems of blindness, poor eye sight, and doubtful clinical usefulness of indole compounds

Inactive Publication Date: 2002-10-22
EISIA R&D MANAGEMENT CO LTD
View PDF9 Cites 14 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

In a preclinical stage, there are antiangiogenic agents by various action mechanisms but, since their antitumor effect in a preclinical stage is insufficient, their usefulness in clinical stage is still doubtful and, therefore, there has been a brisk demand for antiangiogenic agents where the effect is reliable.
When blood vessel is proliferated in retina, eyesight gets worse and, when progressed, blindness is resulted.

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Sulfonamide-containing indole compounds
  • Sulfonamide-containing indole compounds
  • Sulfonamide-containing indole compounds

Examples

Experimental program
Comparison scheme
Effect test

production example 1

Ethyl pyruvate N-(5-methyl-2-nitrophpnyl)hydrazone

To a mixed solution of 160 ml of water and 170 ml of concentrated hydrochloric acid was added 75.0 g (493 mmol) of 5-methyl-2-nitroaniline followed by stirring. An aqueous solution (80 ml) of 36.0 g (517 mmol) of sodium nitrite was added dropwise thereinto at -20.degree. C. The reaction solution was added to a solution which was prepared by dissolving ethyl 2-methylacetacetate in 100 ml of ethanol followed by adding 200 ml of a 12N aqueous solution of potassium hydroxide, at -20.degree. C. with stirring during 30 minutes. After the mixture was stirred at the same temperature for 30 minutes, 100 ml of concentrated hydrochloric acid were added and the resulting precipitates were collected by filtration, washed with water and dried in vacuo for overnight. A mixed solution of diethyl ether and hexane was added thereto, and the resulting crystals were collected by filtration to give 130 g of the title compound.

.sup.1 H-NMR (DMSO-d.sub.6) ...

production example 2

Ethyl 4-methyl-7-nitro-1H-indole-2-carboxylate

To 250 ml of a suspension of 25.0 g (94.2 mmol) of the compound of Production Example 1 in xylene was added 100 g of polyphosphoric acid followed by heating under reflux for 3 hours. To the reaction solution were added 80 ml of water and 300 ml of ethyl acetate under ice-cooling. The resulting insoluble matters were filtered off followed by washing with 1.5 liters of ethyl acetate, and the resulting filtrate was extracted with ethyl acetate. The organic layer was successively washed with a saturated sodium bicarbonate solution, water and brine, dried over magnesium sulfate and concentrated to dryness. To the resulting residue was added a mixed solution of tert-butyl methyl ether and hexane, and the resulting crystals were collected by filtration to give 11.1 g of the title compound.

.sup.1 H-NMR (DMSO-d.sub.6) .delta. (ppm); 1.35(3H, t, J=7.2 Hz), 2.65(3H, s), 4.38(2H, q, J=7.2 Hz), 7.16(1H, d, J=8.4 Hz), 7.51(1H, s), 8.19(1H, d, J=8.4 Hz...

production example 3

4-Methyl-7-nitron-1H-indole-2-carboxylic Acid

To 150 ml of a solution of 11.0 g (44.3 mmol) of the compound of Production Example 2 in tetrahydrofuran was added 150 ml of a 1N aqueous solution of sodium hydroxide followed by heating under stirring at 80.degree. C. for 30 minutes. The reaction solution was concentrated, 40 ml of 5N hydrochloric acid was added to the resulting residue under ice-cooling to adjust to pH 1, and the resulting precipitates were filtered and washed with water. The precipitates were dissolved in 300 ml of tetrahydrofuran and extracted with ethyl acetate. The organic layer was washed with brine, dried over magnesium sulfate and concentrated to dryness to give 9.60 g of the title compound.

.sup.1 H-NMR (DMSO-d.sub.6) .delta. (ppm); 2.62(3H, s), 7.13(1H, d, J=8.0 Hz), 7.42(1H, S), 8.15(1H, d, J=8.0 Hz), 11.00(1H, brs).

Prduction Example 4

4-Methyl-7-nitro-1H-indole

Into 60 ml of 1,3-dimethyl-2-imidazolidinone was dissolved 9.58 g (43.5 mmol) of the compound of Produ...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

PropertyMeasurementUnit
concentrationaaaaaaaaaa
wave lengthaaaaaaaaaa
pHaaaaaaaaaa
Login to View More

Abstract

The present invention creates a novel antiangiogenic agent and provides an antitumor agent which shows high safety as compared with conventional antitumor agents, has a sure effect and is able to be administered for a long period. That is, it provides an indole compound represented by the following formula (I), its pharmacologically acceptable salt or hydrates thereof.In the formula, R1 represents hydrogen atom, a halogen atom or cyano group; R2 and R3 are the same as or different from and each represents hydrogen atom, a C1~C4 lower alkyl group or a halogen atom; R4 represents hydrogen atom or a C1~C4 lower alkyl group; and the ring A represents cyanophenyl group, aminosulfonylphenyl group, aminopyridyl group, aminopyrimidyl group, a halopyridyl group or cyanothiophenyl group, provided that the case where all of R1, R2 and R3 are hydrogen atoms, where both R2 and R3 are hydrogen atoms or where the ring A is aminosulfonyl group and both R1 and R2 are halogen atoms is excluded. Further, when the ring A is cyanophenyl group, 2-amino-5-pyridyl group or a 2-halo-5-pyridyl group and R1 is cyano group or a halogen atom, at least one of R2 and R3 should not be a hydrogen atom.

Description

The present invention relates to a sulfonamide-containing indole compound and to an antiangiogenic effect thereof. More particularly, it relates to an antitumor agent, a cancer metastasis suppressor, a therapeutic agent for diabetic retinopathy, a therapeutic agent for rheumatic arthritis and a therapeutic agent for hematoma on the basis of an antiangiogenic effect.PRIOR ARTIt has become clear that there is a close relation between proliferation of cancer and angiogenesis. Thus, when angiogenesis is not generated at the site of cancer, the cancer remains in a state of dormant tumor. However, it has become clarified that, when angiogenesis is generated, oxygen and nutrients in blood are supplied to the tumor whereby proliferation and metastasis of cancer are promoted resulting in a clinically malignant state. Accordingly, it is expected that, when angiogenesis of cancer is suppressed, proliferation and metastasis of cancer can be suppressed. Since angiogenetic vessels are composed of...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Patents(United States)
IPC IPC(8): C07D403/12C07D209/00C07D209/30C07D209/04C07D209/42C07D409/12C07D409/00C07D401/00C07D403/00C07D401/12A61K31/00A61K31/38A61K31/40A61K31/403A61K31/404A61K31/44A61K31/4427A61K31/4433A61K31/4439A61K31/505A61K31/506A61P19/00A61P19/02A61P27/00A61P27/02A61P29/00A61P35/00A61P35/04A61P43/00C07D209/08
CPCC07D209/04C07D209/30C07D209/42C07D401/12C07D403/12C07D409/12A61P19/00A61P19/02A61P27/00A61P27/02A61P29/00A61P35/00A61P35/04A61P43/00
Inventor HANEDA, TORUTSURUOKA, AKIHIKOKAMATA, JUNICHIOKABE, TADASHITAKAHASHI, KEIKONARA, KAZUMASAHAMAOKA, SHINICHIUEDA, NORIHIROOWA, TAKASHIWAKABAYASHI, TOSHIAKIFUNAHASHI, YASUHIROSEMBA, TAROHATA, NAOKOYAMAMOTO, YUJIOZAWA, YOICHITSUKAHARA, NOAKO
Owner EISIA R&D MANAGEMENT CO LTD
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com